What's breaking now, across thousands of outlets.
The Trump administration is rolling out a new model that aims to bring most-favored nation pricing to the Medicaid space.
We haven't written up this one. Fierce Healthcare has the full story — the link below goes straight to it.
(MedPage Today) -- On September 9, the 5th Circuit Court of Appeals heard oral arguments in Louisiana et al. v. FDA et al., a case challenging the FDA's regulation of mifepristone (Mifeprex).
A new study of nearly 4,000 older adults reveals that daily variations in the stress hormone cortisol predict cognitive decline.
Injectable weight-loss treatments are becoming increasingly popular in the Philippines but health experts are warning Filipinos against self-medication and purchasing unregistered or compounded…
The "most favored nation" drug pricing deals that Pfizer and Eli Lilly signed with the Trump administration suggest the companies will give the government a share of increased revenue they generate…
CVS Health's Omnicare unit has started voluntary Chapter 11 bankruptcy proceedings as it navigates a series of legal challenges.
Saudi Health Ministry reiterates that walking 8,000 steps daily strengthens the heart, increases activity, and reduces the risk of premature death.
